Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

Metastatic colorectal cancer (mCRC), like many cancers, is primarily a disease of elderly people. Despite this prevalence, such patients are often excluded from randomized trials or represent a minority of enrolled patients. Moreover, the criteria for establishing benefit or side effects of treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289484/
https://www.ncbi.nlm.nih.gov/pubmed/25584021
http://dx.doi.org/10.2147/CIA.S54675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289484/
https://www.ncbi.nlm.nih.gov/pubmed/25584021
http://dx.doi.org/10.2147/CIA.S54675

Ejemplares similares